Dermatology Consultations From the Hematology Department: A Retrospective Single‐Center Analysis
Open Access
- 1 January 2025
- journal article
- Published by Wiley in Dermatologic Therapy
- Vol. 2025 (1)
Abstract
Introduction: Hematological disorders are often associated with dermatological conditions due to immune dysregulation and the use of polypharmacy. Such dermatological manifestations have the potential to impair quality of life and may also result in morbidity and mortality. Furthermore, in some instances, it may be necessary to modify the treatment regimen. Methods: This study retrospectively evaluated dermatological consultations for patients in a hematology clinic, assessing clinical and demographic data, dermatological diagnoses, and the effects on hematological treatment and prognosis. Results: The data from 434 consultations involving 304 patients were subjected to analysis, with the most prevalent hematological diagnoses being acute myeloid leukemia, multiple myeloma, and myelodysplastic syndrome. The majority of consultations (70.7%, n = 307) were inpatient, while the remainder were outpatient. The most frequently observed dermatological conditions were infections (37.3%) and drug reactions (15.7%). In 39.4% ( n = 171) of cases, dermatological findings led to modifications in systemic treatment, primarily due to infections and drug reactions. Among these patients, 19 required modifications to their hematological treatment regimen. A diagnosis was reached through clinical examination in 74.9% of patients. In other cases, additional diagnostic procedures were necessary, including dermoscopy, histopathology, and microbial examination. The in‐hospital mortality rate was 2.3% ( n = 7). Only one death was directly associated with a dermatological condition: toxic epidermal necrolysis in a patient receiving brentuximab vedotin. Conclusion: The results of this study highlight the importance of dermatological assessment in patients with hematological conditions. It is also crucial for clinicians to be more aware of the potential dermatological manifestations, including infections and drug reactions, that may occur in these patients.Keywords
This publication has 23 references indexed in Scilit:
- Clinicopathologic features of ecthyma gangrenosum: a single integrated health system cohortArchives of Dermatological Research, 2023
- Antifungal prophylaxis and pre-emptive therapy: When and how?Molecular Aspects of Medicine, 2023
- Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virusAnnals of Hematology, 2022
- Cutaneous leukocytoclastic vasculitis induced by continuous erythropoietin receptor activatorJAAD Case Reports, 2021
- Supportive oncodermatology—a narrative review of its utility and the way forwardSupportive Care in Cancer, 2021
- Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive ReviewAmerican Journal of Clinical Dermatology, 2020
- Where are we now with inpatient consultative dermatology?: Assessing the value and evolution of this subspecialty over the past decadeJournal of the American Academy of Dermatology, 2019
- The skin as a window to the blood: Cutaneous manifestations of myeloid malignanciesBlood Reviews, 2017
- Inpatient dermatology consultation in patients with hematologic malignanciesJournal of the American Academy of Dermatology, 2016
- Extensive toxic epidermal necrolysis following brentuximab vedotin administrationAnnals of Hematology, 2014